PTCA术后再狭窄与雌激素替代治疗
刘君,傅向华
摘要(Abstract)：
经皮冠状动脉腔内成形术（Ｐｅｒｃｕｔａｎｅｏｕｓｔｒａｎｓｌｕ－ｍｉｎａＬ ｃｏｒｏｎａｒｙ ａｎｇｉｏｐｌａｓｔｙ ＰＴＣＡ）已成为当今冠心病治疗的主要手段，在国际上广为应用，仅美国一年例数已超过５０万例，我国从１９８７年起陆续在各地开展ＰＴＣＡ，...
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 刘君,傅向华
参考文献(References)：
- 1 Popma J, califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation, 1991, 84:1426-1436.
- 2 Forrester JS, Fishbein MC, Helfant RH, et al. A paradiam for restenosis based on cell biology: clues for thedevelopment of new preventive therapies. J Am CoilCardiol, 1991, 17: 758-768.
- 3 Majesky MW, Reidy MA, rowen-Pope DF, et al.PDGF ligand and receptor gene expression during repairof arterial injury. J Cell Biol, 1990, 66: 1755-1760.
- 4 Lindner V, Reidy MA. Proliferation of smooth musclecells after vascular injury is inhibited by an antibodyagainst basic fibroblast growth factor. Proc Nail AcadSci USA, 1991,88: 3739-3743.
- 5 Cercek B, Fishbein MC, Forrester JS, et al. Inductionof insulin-like growth factor I messenger RNA in rataorta after balloon denudation. Circ Res, 1990, 66: 1755-1760.
- 6 Patrick WS, Peter De J, Ferdinand K, et al. A comparison of balloon expansion stent implantation with balloonangioplasty in patients with coronary artery disease. NEngl J Med, 1994,331:489--495.
- 7 Topol EJ, Ferguson JJ, Weisman HF, et al. Long-termprotection from myocardial ischemic events in a randomized trial of brief integrin B3 blockade with percutaneouscoronary intervention. EPIC investigator group. Evaluation of platelet II b/ III a inhibition for prevention of ischemic complication. JAMA, 1997, 278: 479-491.
- 8 Rainier AE,Hollman J, Abukhalil J,et al. Ciprostenefor restenosis revisited: Quantitative analysis of angiograms, J Am Coil Cardiol, 1993, 2: 321A--332A.
- 9 ACCORD Study investigators, Nitric oxide donorsreduce restenosis after coronary angioplasty: TheACEERD study. J Am Coil Cardiol, 1994, 23(Suppl I ):59A~68A.
- 10 Tremollieres FA, Pouilles JM, Cauneille C, et al. Coronary heart disease risk factors and menopause:a study in1684 French women. Atherosclerosis, 1999, 142: 415-23.
- 11 Consensus Development conference Report: Prophylaxisand Treatment of osteoporosis. Am J Med, 1991, 90:107-110.
- 12 O'Keefe JH Jr, Kim SC, Hall RR, et al. Estrogen replacement therapy after coronary angioplasty in women.J Am Coil Cardiol, 1997, 29: 1--5.
- 13 Abu-Haiawa SA, Thompson K, Kirkeeide RL, et al.Estrogen replacement therapy and outcome of coronaryballoon angioplasty in postmenopausal women. Am JCardiol, 1998, 15; 82: 409-413.
- 14 O'Brien JE, peterson ED, Keeler GP, et al. Relationbetween estrogen replacement therapy and restenosisafter percutaneous coronary interventions. J Am CoilCardiol, 1996, 1, 28: 1111--1118.
- 15 The Writing Group for the PEPI trial. Effects of estrogenor estrogen/progestin regimens on heart disease riskfactors in postmenopausal women: The PostmenopausalEstrogen/Progestin interventions (PEPI) Trial. JAMA,1 995, 273: 199-208.
- 16 Frohlich M, Schunkert H, Hense HW, et al. Effects ofhormone replacement therapies on fibrinogen and plasmaviscosity in postmenopausal women. Br J Haematol,1 998, 100: 577-581.
- 17 Gebara OC, Mittleman MA, Suther P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.Circulation, 1995, 91: 1952-1958.
- 18 Tagawa H, Tagawa T, Shimokawa H. Estrogen acutelyimproves both nitric oxide-mediated and non nitric oxide-mediated endothelium-dependent vasosidatation in post- menopausal women. Circulation, 1995, 92 (Suppl 1 ): 168.
- 19 Williams JK, Adams MR, Klopfenstein HS. Estrogenmodulates responses of atherosclerotic coronary arteries.Circulation, 1990, 81: 1680- 1687.
- 20 Stefanadis C, Tsiamis E, Dernellis J, et al. Effect ofestrogen on aortic function in postmenopausal women.Am J Physiol, 1999, 276(2 Pt 2): H658-662.
- 21 Sbarouni E, Kyriakides ZS, Kremastions DT. Effect ofintracoronary estrogen on coronary collateral blood flowvelocity. Am J Cardiol, 1997, 79: 666-669.
- 22 Coffins P, Rosano G, Sarrel PM, et al. 17b-Estradiolattenuates acetylcholine-induced coronary arterialconstriction in women but not men with coronary arterydisease. Circulation, 1995, 92: 24-30.
- 23 Oparil S. Corcoran Memorial Lecture. Hormones andVasoprotection. Hypertension 1999; 33 (l Pt 2 ): 170-176.
- 2